DETERMINANTS OF DRUG REMOVAL BY CONTINUOUS HEMOFILTRATION

被引:17
作者
LAU, AH [1 ]
KRONFOL, NO [1 ]
机构
[1] UNIV ILLINOIS,DEPT MED,CHICAGO,IL
关键词
DRUG REMOVAL; CONTINUOUS HEMOFILTRATION; MOLECULAR WEIGHTS; PROTEIN BINDING;
D O I
10.1177/039139889401700702
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Continuous hemofiltration was conducted in vitro to identify parameters that affect drug transport across hemofilter membranes. The removal of seven drugs with different molecular weights and protein binding characteristics was assessed. Sieving coefficients were determined with both blood and saline using polysulfone, polyacrylonitrile and polyamide membranes. Drug sieving coefficients obtained with saline were generally higher than those obtained with blood. Molecular weights of the drugs did not correlate with the magnitude of drug sieving. Sieving coefficients in blood were also predicted from saline data assuming plasma protein binding is responsible for the reduced drug sieving with blood. For drugs that are highly protein bound, protein binding was the primary factor limiting drug sieving. Presence of plasma proteins also had a modest effect on sieving of other drugs. The sieving coefficients obtained with the polyacrylonitrile membrane tend to be different from those obtained with the other hemofilters. Drug-membrane interaction may contribute to the differences in drug transport among the membranes.
引用
收藏
页码:373 / 378
页数:6
相关论文
共 11 条
[1]   GENTAMICIN AND PHENYTOIN SIEVING THROUGH HOLLOW FIBER POLYSULFONE HEMOFILTERS [J].
GOLPER, TA ;
SAAD, AMA ;
MORRIS, CD .
KIDNEY INTERNATIONAL, 1986, 30 (06) :937-943
[2]  
HENDERSON LW, 1975, J LAB CLIN MED, V85, P372
[3]  
KRONFOL NO, 1986, T AM SOC ART INT ORG, V32, P85
[4]   EFFECT OF CONTINUOUS HEMOFILTRATION ON PHENYTOIN ELIMINATION [J].
LAU, AH ;
KRONFOL, NO .
THERAPEUTIC DRUG MONITORING, 1994, 16 (01) :53-57
[5]  
LAU AH, 1987, T AM SOC ART INT ORG, V32, P297
[6]   CONTINUOUS ARTERIOVENOUS HEMOFILTRATION IN THE CRITICALLY ILL PATIENT - CLINICAL USE AND OPERATIONAL CHARACTERISTICS [J].
LAUER, A ;
SACCAGGI, A ;
RONCO, C ;
BELLEDONNE, M ;
GLABMAN, S ;
BOSCH, JP .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (04) :455-460
[7]  
LEYPOLDT JK, 1983, T AM SOC ART INT ORG, V29, P678
[8]  
LEYPOLDT JK, 1986, T AM SOC ART INT ORG, V32, P384
[9]  
ODARCEDERLOF I, 1976, CLIN PHARMACOL THER, V20, P36
[10]  
RUBIN JE, 1978, T AM SOC ART INT ORG, V24, P471